TRex Bio Funding & Investors
TRexBio is a discovery stage biotechnology company leveraging cutting edge computational biology tools, a focus on human tissue, and expertise in immunobiology to develop revolutionary therapeutics for cancer and inflammatory diseases.
trex.bioTotal Amount Raised: $85,000,000
TRex Bio Funding Rounds
Series A
$26,000,000
Series A Investors
Polaris PartnersSV Health InvestorsEli LillyAlexandria Venture InvestmentsPfizer Venture InvestmentsLaurion Capital ManagementJohnson & Johnson InnovationSeries A
$59,000,000
Series A Investors
Alexandria Venture InvestmentsJohnson & Johnson Robotics and Digital SolutionsSV Health InvestorsPfizer Venture InvestmentsEli Lilly
Funding info provided by Diffbot.